Eclipse Regenesis Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 14

Eclipse Regenesis General Information

Description

Developer of a tissue regeneration platform designed for short bowel syndrome treatment. The company's technology offers distraction enterogenesis, tissue regeneration therapy, mechanical intestinal lengthening, implantable device design, minimally invasive endoscopic development, preclinical intestinal modeling, and translational research, enabling short bowel syndrome patients to regrow healthy intestinal tissue naturally to increase nutrient absorption and reduce reliance on lifelong intravenous feeding.

Contact Information

Formerly Known As
Eclipse Enterogenesis
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Sobrato Pavilion, 2495 Hospital Drive
  • Suite 300
  • Mountain View, CA 94040
  • United States
Primary Industry
Other Devices and Supplies
Corporate Office
  • Sobrato Pavilion, 2495 Hospital Drive
  • Suite 300
  • Mountain View, CA 94040
  • United States

Eclipse Regenesis Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eclipse Regenesis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 11-Aug-2025 Completed Generating Revenue
10. Later Stage VC (Series A) 25-Apr-2023 Completed Generating Revenue
9. Grant 01-Jan-2023 Completed Generating Revenue
8. Accelerator/Incubator 15-Aug-2022 Completed Generating Revenue
7. Grant 26-Aug-2021 Completed Generating Revenue
6. Grant 02-Apr-2021 Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
3. Accelerator/Incubator 01-Jun-2020 Completed Generating Revenue
2. Grant 30-Mar-2020 $50K Completed Generating Revenue
To view Eclipse Regenesis’s complete valuation and funding history, request access »

Eclipse Regenesis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A
To view Eclipse Regenesis’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Eclipse Regenesis Patents

Eclipse Regenesis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026107214-A1 Plication anchoring devices and systems, hemostasis clips and systems, and methods for using same Pending 13-Nov-2024
EP-4761676-A1 Systems and methods for distending a tubular organ and/or enhancing nutrient absorption Pending 16-Aug-2023
WO-2025038884-A1 Systems and methods for distending a tubular organ and/or enhancing nutrient absorption Inactive 16-Aug-2023
AU-2023444280-A1 Plication systems, plication/spring systems, and methods of use thereof Pending 18-Apr-2022
EP-4510972-A1 Plication systems, plication/spring systems, and methods of use thereof Pending 18-Apr-2022 A61F2/04
To view Eclipse Regenesis’s complete patent history, request access »

Eclipse Regenesis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eclipse Regenesis Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Impact Assets Impact Investing Minority
Atacama Ventures Venture Capital Minority
Cloudstone Capital Venture Capital Minority
MainSheet Ventures Venture Capital Minority
SVE Capital Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Eclipse Regenesis FAQs

  • When was Eclipse Regenesis founded?

    Eclipse Regenesis was founded in 2017.

  • Where is Eclipse Regenesis headquartered?

    Eclipse Regenesis is headquartered in Mountain View, CA.

  • What is the size of Eclipse Regenesis?

    Eclipse Regenesis has 8 total employees.

  • What industry is Eclipse Regenesis in?

    Eclipse Regenesis’s primary industry is Other Devices and Supplies.

  • Is Eclipse Regenesis a private or public company?

    Eclipse Regenesis is a Private company.

  • What is Eclipse Regenesis’s current revenue?

    The current revenue for Eclipse Regenesis is .

  • How much funding has Eclipse Regenesis raised over time?

    Eclipse Regenesis has raised $9.3M.

  • Who are Eclipse Regenesis’s investors?

    Impact Assets, Atacama Ventures, Cloudstone Capital, MainSheet Ventures, and SVE Capital are 5 of 14 investors who have invested in Eclipse Regenesis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process